Publication | Open Access
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis
172
Citations
20
References
2018
Year
Cancer ImmunosurveillanceMedicineRecist ProgressionImmunologyMelanomaImmune Checkpoint InhibitorImmunotherapeuticsDrug AdministrationImmunotherapyOncologyRadiation OncologyUs FoodSkin Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1